Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

This study has been completed.
Ministry of Education, Thailand
National Health Security Office, Thailand
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration Identifier:
First received: October 18, 2010
Last updated: March 26, 2015
Last verified: March 2015